title: Ruxolitinib Attenuates Cutaneous Lupus Development in a Mouse Lupus Model.
authors: College of Physicians and Surgeons, Columbia University, New York, New York, USA.
authors: Emilie S
authors: ES
authors: Chan
authors: Department of Pathology, Columbia University Medical Center, New York, New York, USA.
authors: Leal C
authors: LC
authors: Herlitz
authors: Department of Dermatology, Columbia University Medical Center, New York, New York, USA. Electronic address: aj2446@columbia.edu.
authors: Ali
authors: A
authors: Jabbari
mesh_terms: D000284:Administration, Oral; D000818:Animals; D001707:Biopsy, Needle; D004195:Disease Models, Animal; D005260:Female; D007150:Immunohistochemistry; D053612:Janus Kinases / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D008178:Lupus Erythematosus, Cutaneous / Q000188:drug therapy* / Q000473:pathology*; D051379:Mice; D019463:Mice, Inbred MRL lpr; D009570:Nitriles; D011720:Pyrazoles / Q000494:pharmacology*; D011743:Pyrimidines; D011897:Random Allocation; D016896:Treatment Outcome
chemical_list: D009570:Nitriles; D011720:Pyrazoles; D011743:Pyrimidines; C540383:ruxolitinib; D053612:Janus Kinases